Against Rs 730 Cr of EBITDA by PCBL for FY23, Aquapharm had EBITDA of Rs 417 Cr. Also, EBITDA margins at c. 20% are higher as compared to 13-14% of PCBL.
Subscribe To Our Free Newsletter |
Against Rs 730 Cr of EBITDA by PCBL for FY23, Aquapharm had EBITDA of Rs 417 Cr. Also, EBITDA margins at c. 20% are higher as compared to 13-14% of PCBL.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!